Inflammation & Allergy - Drug Targets (Discontinued)
Title: Preface
Volume: 5 Issue: 1
Author(s): Prem L. Bhalla and Mohan B. Singh
Affiliation:
Export Options
About this article
Cite this article as:
Bhalla L. Prem and Singh B. Mohan, Preface, Inflammation & Allergy - Drug Targets (Discontinued) 2006; 5 (1) . https://dx.doi.org/10.2174/187152806775269268
DOI https://dx.doi.org/10.2174/187152806775269268 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Journals
Related Books
9
Related Articles
-
Tumoricidal and Anti-Angiogenic Actions of Gamma-Linolenic Acid and Its Derivatives
Current Pharmaceutical Biotechnology Therapy of Chronic Hepatitis C: A Critical Review
Current Drug Targets - Infectious Disorders Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design Flunarizine Dihydrochloride Nanoemulsion for Migraine Nasal Drug Delivery: Fabrication, Characterization and In Vitro Study
Drug Delivery Letters Introduction from Editor-in-Chief
Current Rheumatology Reviews Biomarker Assessment in Nutritional Modulation of Oxidative Stress-Induced Cancer Development by Lipid-Related Bioactive Molecules
Recent Patents on Anti-Cancer Drug Discovery From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
Current Neuropharmacology Network Building of Proteins in a Biochemical Pathway: A Computational Biology Related Model for Target Discovery and Drug-Design
Current Bioinformatics Novel Research Strategies of Benzimidazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Cellular and Molecular Effects of Macrolides on Leukocyte Function
Current Pharmaceutical Design Opioid Free Anaesthesia and Cancer
Current Pharmaceutical Design Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Novel Nanocarriers for the Treatment of Wound Healing
Current Pharmaceutical Design Anti-Inflammatory Effects of Plasma Circulating Exosomes Obtained from Normal-Weight and Obese Subjects on Hepatocytes
Endocrine, Metabolic & Immune Disorders - Drug Targets Depression in Schizophrenia, Can it be Treated? A Review of the Evidence
Current Psychiatry Reviews Modulation of the Ceramide Level, A Novel Therapeutic Concept
Current Drug Targets Effects of Natural Products on Mcl-1 Expression and Function
Current Medicinal Chemistry Editorial [ Are Peptide Therapeutics the Future? Guest Editor: Sivaram Pillarisetti ]
Current Pharmaceutical Biotechnology Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study
CNS & Neurological Disorders - Drug Targets Liver Injury Associated with Antidepressants
Current Drug Safety